These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34971717)

  • 1. Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system.
    Sturm LK; Saake K; Roberts PB; Masoudi FA; Fakih MG
    Am J Infect Control; 2022 Mar; 50(3):245-249. PubMed ID: 34971717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
    Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
    BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hospital-onset bloodstream infections compared to central line...associated bloodstream infections at an acute, tertiary care hospital.
    Gurney H; White J; Sweeney J; Valyko A; Washer L
    Am J Infect Control; 2023 Oct; 51(10):1120-1123. PubMed ID: 37054893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control.
    Pérez-Granda MJ; Carrillo CS; Rabadán PM; Valerio M; Olmedo M; Muñoz P; Bouza E
    J Hosp Infect; 2022 Jan; 119():149-154. PubMed ID: 34627934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts.
    Fakih MG; Bufalino A; Sturm L; Huang RH; Ottenbacher A; Saake K; Winegar A; Fogel R; Cacchione J
    Infect Control Hosp Epidemiol; 2022 Jan; 43(1):26-31. PubMed ID: 33602361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
    Amarsy R; Trystram D; Cambau E; Monteil C; Fournier S; Oliary J; Junot H; Sabatier P; Porcher R; Robert J; Jarlier V;
    Int J Infect Dis; 2022 Jan; 114():90-96. PubMed ID: 34688945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage.
    Zhu NJ; Rawson TM; Mookerjee S; Price JR; Davies F; Otter J; Aylin P; Hope R; Gilchrist M; Shersing Y; Holmes A
    Clin Infect Dis; 2022 Aug; 75(1):e1082-e1091. PubMed ID: 34596212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
    Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D
    Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the coronavirus disease 2019 (COVID-19) pandemic with the incidence of healthcare-associated infections in California hospitals.
    Parriott AM; Kazerouni NN; Epson EE
    Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1429-1436. PubMed ID: 36382922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based bloodstream infection surveillance in rural Thailand, 2007-2014.
    Rhodes J; Jorakate P; Makprasert S; Sangwichian O; Kaewpan A; Akarachotpong T; Srisaengchai P; Thamthitiwat S; Khemla S; Yuenprakhon S; Paveenkittiporn W; Kerdsin A; Whistler T; Baggett HC; Gregory CJ
    BMC Public Health; 2019 May; 19(Suppl 3):521. PubMed ID: 32326935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased incidence of late-onset sepsis during the SARS-CoV-2 pandemic in Italy: a multicentric study on a cohort of infants requiring major surgery.
    De Rose DU; Santisi A; Ronchetti MP; Martini L; Serafini L; Betta P; Maino M; Cavigioli F; Giuffré M; Bonanno E; Tzialla C; Bua J; Pugni L; Della Torre B; Nardella G; Mazzeo D; Ravà L; Bagolan P; Dotta A; Auriti C;
    Eur J Pediatr; 2023 Nov; 182(11):4859-4866. PubMed ID: 37582826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic.
    Taddei E; Pafundi PC; Masciocchi C; Fiori B; Segala FV; Antenucci L; Guerriero S; Pastorino R; Scarsi N; Damiani A; Sanguinetti M; De Pascale G; Fantoni M; Murri R; De Angelis G
    Infect Dis (Lond); 2023 Nov; 55(11):776-785. PubMed ID: 37750316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study.
    Pasquini Z; Barocci I; Brescini L; Candelaresi B; Castelletti S; Iencinella V; Mazzanti S; Procaccini G; Orsetti E; Pallotta F; Amadio G; Giacometti A; Tavio M; Barchiesi F
    Int J Infect Dis; 2021 Oct; 111():31-36. PubMed ID: 34416402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising health care-associated bloodstream infections in public hospitals in Queensland, 2008-2012.
    Si D; Runnegar N; Marquess J; Rajmokan M; Playford EG
    Med J Aust; 2016 Apr; 204(7):276. PubMed ID: 27078605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study.
    Anderson DJ; Moehring RW; Sloane R; Schmader KE; Weber DJ; Fowler VG; Smathers E; Sexton DJ
    PLoS One; 2014; 9(3):e91713. PubMed ID: 24643200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on the incidence and mortality of hospital-onset bloodstream infection: a cohort study.
    Valik JK; Hedberg P; Holmberg F; van der Werff SD; Nauclér P
    BMJ Qual Saf; 2022 May; 31(5):379-382. PubMed ID: 35042764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.